Mostrar el registro sencillo del ítem
dc.contributor.author
Villela Nogueira, Cristiane A.
dc.contributor.author
Ferraz, Maria Lúcia Gomes
dc.contributor.author
Pessoa, Mário Guimarães
dc.contributor.author
Souto, Francisco José Dutra
dc.contributor.author
Nabuco, Letícia Cancella
dc.contributor.author
Coelho, Henrique Sérgio Moraes
dc.contributor.author
Ridruejo, Ezequiel
dc.contributor.author
Silva, Marcelo
dc.contributor.author
Bittencourt, Paulo Lisboa
dc.contributor.author
Brandão Mello, Carlos Eduardo
dc.date.available
2024-02-28T14:52:26Z
dc.date.issued
2023-01
dc.identifier.citation
Villela Nogueira, Cristiane A.; Ferraz, Maria Lúcia Gomes; Pessoa, Mário Guimarães; Souto, Francisco José Dutra; Nabuco, Letícia Cancella; et al.; Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver: Choosing Wisely Brazil and viral hepatitis; Mexican Association of Hepatology; Annals of Hepatology; 28; 1; 1-2023
dc.identifier.issn
1665-2681
dc.identifier.uri
http://hdl.handle.net/11336/228820
dc.description.abstract
Introduction and Objectives: The Choosing Wisely (CW) initiative aims to improve daily practice supported by evidence concerning unnecessary medical tests, procedures, and treatments. This philosophy is essential in managing viral hepatitis (VH), which primary care physicians increasingly carry out. It is also essential to achieving disease elimination. Thus, the aim of our study was to propose evidence-based CW recommendations in VH. Methods: The Brazilian Society of Hepatology (SBH) formed a panel of experts in VH who selected evidence-based CW recommendations, which were subsequently scrutinized and ranked by all members of SBH using a web-based approach. Results: Five recommendations were chosen in order of importance: 1) do not order anti-HCV testing after achieving sustained virological response; 2) do not request serial HCV viral load to evaluate HCV progression, 3) do not add ribavirin to direct-acting antivirals in non-cirrhotic, naïve HCV patients; 4) do not screen for hepatocellular carcinoma in HCV patients with none to moderate fibrosis (≤ F2); 5) do not request anti-HBs after HBV vaccination, except for children born to HBV-infected mothers, hemodialysis patients, healthcare professionals, people who have had sexual contact with chronic HBV carriers, HIV-positive persons and immunocompromised individuals (hematopoietic stem-cell transplant recipients or persons receiving chemotherapy). Conclusion: CW recommendations may help general practitioners adopt a more rational and cost-effective approach in managing patients with VH in Brazil and Latin America, leading to lesser waste or harm to patients.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Mexican Association of Hepatology
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
CARE QUALITY
dc.subject
HBV
dc.subject
HCV
dc.subject
RECOMMENDATIONS
dc.subject
VACCINE
dc.subject
VIRUS
dc.subject.classification
Gastroenterología y Hepatología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver: Choosing Wisely Brazil and viral hepatitis
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2024-02-28T10:36:13Z
dc.journal.volume
28
dc.journal.number
1
dc.journal.pais
México
dc.description.fil
Fil: Villela Nogueira, Cristiane A.. Universidade Federal do Rio de Janeiro; Brasil
dc.description.fil
Fil: Ferraz, Maria Lúcia Gomes. Universidade Federal de Sao Paulo; Brasil
dc.description.fil
Fil: Pessoa, Mário Guimarães. Universidade de Sao Paulo; Brasil
dc.description.fil
Fil: Souto, Francisco José Dutra. Universidade Federal do Mato Grosso do Sul; Brasil
dc.description.fil
Fil: Nabuco, Letícia Cancella. Universidade Federal do Rio de Janeiro; Brasil
dc.description.fil
Fil: Coelho, Henrique Sérgio Moraes. Universidade Federal do Rio de Janeiro; Brasil
dc.description.fil
Fil: Ridruejo, Ezequiel. Centro de Educación Medica E Invest.clinicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Silva, Marcelo. Universidad Austral; Argentina
dc.description.fil
Fil: Bittencourt, Paulo Lisboa. Escola Bahiana de Medicina e Saúde Pública; Brasil
dc.description.fil
Fil: Brandão Mello, Carlos Eduardo. Universidade do Estado de Rio do Janeiro; Brasil
dc.journal.title
Annals of Hepatology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.aohep.2022.100764
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1665268122001065
Archivos asociados